Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 94
Filter
1.
Indian J Psychiatry ; 60(Suppl 2): S224-S226, 2018 Feb.
Article in English | MEDLINE | ID: mdl-29527052

ABSTRACT

Since 1979, consistent and untiring efforts of Dr. D.R. Purohit, Dr. Mahaveer Chand Jain and Dr. G. D. Koolwal against the odds have brought remarkable changes in the Psychiatric centre, Jodhpur.

2.
Stud Health Technol Inform ; 181: 27-31, 2012.
Article in English | MEDLINE | ID: mdl-22954822

ABSTRACT

We are entering a new age where people routinely visit, inhabit, play in and learn within virtual worlds (VWs). One in eight people worldwide are VW participants, according to the latest 2011 figures from KZERO [1]. VWs are also emerging as a new and advanced form of telehealth care delivery. In addition to existing telehealth care advantages; VWs feature three powerful affordances that can benefit a wide range of physical and psychological issues. First, the highly social nature of VWs encourages social networking and the formation of essential support groups. Secondly, the type of spaces that have been proven in the physical world to promote psychological health and well-being can be virtually recreated. Finally, research suggests that embodied avatar representation within VWs can affect users psychologically and physically. These three aspects of VWs can be leveraged for enhanced patient-client interactions, spaces that promote healing and positive responses, and avatar activities that transfer real benefits from the virtual to the physical world. This paper explains the mounting evidence behind these claims and provides examples of VWs as an innovative and compelling form of telehealth care destined to become commonplace in the future.


Subject(s)
Computer Simulation , Social Networking , Telemedicine/trends , User-Computer Interface , Humans , Self Concept , Social Support , Video Games
3.
Int J Alzheimers Dis ; 2012: 673849, 2012.
Article in English | MEDLINE | ID: mdl-22792507

ABSTRACT

Rapid rise in the population of older adults in India will lead to the need for increased health care services related to diagnosis, management, and long-term care for those with dementia and cognitive impairment. A direct approach for service provision through memory clinics can be an effective, successful, and sustaining means of delivering specialized health care services. We have established a memory clinic in Mumbai, India by employing the diverse clinical skills available in Indian academic institutions, diagnostic and research expertise of clinicians and psychologists, and the support of the U.S. National Institutes of Health. Our project involved recruitment of patients, clinical and neuropsychological assessment, and standardized diagnostic procedures, demonstrating the feasibility of using research methods to develop a memory clinic. In this paper, we describe the development of a community-based memory clinic in urban India, including linguistic and cultural factors and present detailed results, including diagnostic characterization, on 194 subjects with various stages of cognitive deficits. Our findings support the feasibility of developing a memory clinic in a public hospital and successful use of research diagnostic criteria to categorize cognitive deficits observed in this population, which may be used to inform the development of other such clinics.

4.
Curr Alzheimer Res ; 8(3): 303-12, 2011 May.
Article in English | MEDLINE | ID: mdl-21244352

ABSTRACT

UNLABELLED: Elevated serum total cholesterol (TC) has been considered a risk factor for Alzheimer's disease (AD), but conflicting results have confused understanding of the relationships of serum lipids to the presence of AD in the elderly. METHODS: To clarify these issues, we evaluated correlations of admission TC, low-density (LDL) and high-density (HDL)cholesterol directly with the densities of Alzheimer hallmarks--neuritic plaques (NP) and neurofibrillary tangles (NFT)--in nursing home residents (n=281). RESULTS: Significant positive associations of TC and LDL with NP densities were found in both the neocortex (TC: r=0.151, p=0.013 and LDL: r=0.190, p=0.005) and the hippocampal/entorhinal (allocortical)region (TC: r=0.182, p=0.002 and LDL: r=0.203, p=0.003). Associations of HDL with NP were less strong but also significant.In contrast, after adjustment for confounders, no correlations of NFT with any lipid were significant.When subjects with any non-AD neuropathology (largely vascular) were excluded, the TC-plaque and LDL-plaque associations for the remaining "Pure AD" subgroup were consistently stronger than for the full sample. The TC- and LDL-plaque correlations were also stronger for the subgroup of 87 subjects with an APOE ε4 allele. CONCLUSIONS: The findings indicate that serum TC and LDL levels clearly relate to densities of NP, but not to densities of NFT. The stronger associations found in the subgroup that excluded all subjects with non-AD neuropathology suggest that cerebrovascular involvement does not explain these lipid-plaque relationships. Since the associations of TC/LDL with NP were particularly stronger in ε4 carriers, varying prevalence of this allele may explain some discrepancies among prior studies.


Subject(s)
Alzheimer Disease/blood , Alzheimer Disease/pathology , Apolipoprotein E4/genetics , Cholesterol/blood , Neurofibrillary Tangles/pathology , Plaque, Amyloid/pathology , Aged, 80 and over , Alzheimer Disease/genetics , Cholesterol, LDL/blood , Female , Humans , Male
5.
Neurology ; 72(20): 1720-6, 2009 May 19.
Article in English | MEDLINE | ID: mdl-19228583

ABSTRACT

OBJECTIVE: To test the hypothesis that use of antihypertensive medication is associated with lower Alzheimer disease (AD) neuropathology. METHODS: This was a postmortem study of 291 brains limited to those with normal neuropathology or with uncomplicated AD neuropathology (i.e., without other dementia-associated neuropathology) in persons with or without hypertension (HTN) who were and were not treated with antihypertensive medications. Neuritic plaque (NP) and neurofibrillary tangle (NFT) densities, quantified in selected brain regions according to the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) neuropathologic criteria, with additional cortical NP counts, yielded 24 neuropathologic regional measures or summaries. Medicated hypertension (HTN-med; n = 77), nonmedicated HTN (HTN-nomed; n = 42), and non-HTN (no-HTN; n = 172) groups were compared by analyses of variance. RESULTS: The HTN-med group had significantly less neuropathology than the no-HTN group. The no-HTN group averaged over 50% higher mean NP and NFT ratings, and double the mean NP count, of the HTN-med group. The HTN-nomed group had significantly more neuropathology than the HTN-med group, but not significantly less than the no-HTN group. CONCLUSIONS: There was substantially less Alzheimer disease (AD) neuropathology in the medicated hypertension group than the nonhypertensive group, which may reflect a salutary effect of antihypertensive medication against AD-associated neuropathology.


Subject(s)
Alzheimer Disease/pathology , Antihypertensive Agents/therapeutic use , Dementia/pathology , Hypertension , Aged , Aged, 80 and over , Blood Pressure/physiology , Brain/anatomy & histology , Brain/pathology , Female , Humans , Hypertension/drug therapy , Hypertension/physiopathology , Neurofibrillary Tangles/pathology , Plaque, Amyloid/pathology , Risk Factors
6.
J Dairy Sci ; 92(3): 847-56, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19233777

ABSTRACT

The objective of this research was to evaluate the rheological, sensorial, and chemopreventive properties of milk fermented with different exopolysaccharide (EPS)-producing lactic cultures. Reconstituted skim milk (11% wt/vol) was fermented with single strains of EPS-producing and non-EPS-producing cultures. Whey that collected on the surface of undisturbed fermented milks and after cutting was measured. All EPS-producing cultures reduced the amount of whey present on the surface of the undisturbed samples, whereas only 3 out of 5 strains reduced syneresis measured after cutting. All EPS-producing cultures except a strain of Lactobacillus delbrueckii ssp. bulgaricus reduced viscoelastic moduli in fermented milk. There was a linear correlation between ropiness and smoothness. In the chemoprevention study, 140 male Fisher rats were divided into 7 groups of 20 each. Rats in 6 groups were fed diets supplemented with fermented milks each made with a single strain of EPS-producing or non-producing cultures, whereas rats in group 7 (control) were fed a diet supplemented with milk acidified with glucono-delta-lactone (GDL). All rats were injected with azoxymethane (15 mg/kg, subcutaneous) at wk 7 and 8 of age to induce tumors and fed their respective diets ad libitum throughout the study. After 30 wk of initiation, all rats were anesthetized with ether, and their intestinal tissues were isolated and washed with cold normal saline. The number and size of tumors in the colon and small intestine were recorded. Rats fed diets supplemented with fermented milk made with 2 EPS-positive and 1 EPS-negative strains had significantly lowered incidence of colon tumor and colon tumor multiplicity. Cyclooxygenase-2 enzyme activity (the enzyme implicated in colon tumor development) was significantly lower in the colon tissue of rats fed diets containing milk fermented with 4 EPS-producing and 1 non-producing cultures than that in rats fed diets supplemented with GDL-acidified milk. Different EPS-positive cultures produced fermented milks with distinct rheological characteristics and levels of ropiness. No relationship was found between rheological properties or level of ropiness of fermented milk and its chemopreventive effect.


Subject(s)
Cultured Milk Products/standards , Intestinal Neoplasms/prevention & control , Sensation , Animals , Colon/enzymology , Colonic Neoplasms/prevention & control , Cyclooxygenase 2/metabolism , Diet , Gram-Positive Bacteria , Humans , Male , Rats , Rheology
7.
Neurology ; 71(10): 750-7, 2008 Sep 02.
Article in English | MEDLINE | ID: mdl-18765651

ABSTRACT

OBJECTIVE: To examine the association between treatment for diabetes and Alzheimer disease (AD) neuropathology. METHODS: This postmortem study matched 124 subjects with diabetes to 124 without diabetes from the Mount Sinai School of Medicine Brain Bank, on age (mean = 81.2 + 9.3), sex (57.3% F), and severity of dementia (Clinical Dementia Rating [CDR] 2.4 + 1.7). Densities of neuritic plaques (NPs) and of neurofibrillary tangles (NFTs) were assessed in several neocortical regions and in the hippocampus, entorhinal cortex, and amygdala. Diabetic subjects were classified according to their recorded lifetime antidiabetic medications: none (n = 29), insulin only (n = 49), diabetes medications other than insulin only (n = 28), or concomitant use of both insulin and any oral antidiabetic medications (n = 18). For each dependent variable, analysis of covariance controlling for age at death, sex, and CDR distinguished among the nondiabetic patients and four diabetic subgroups. RESULTS: There were differences among the five groups for NP ratings in the entorhinal cortex (p = 0.003), amygdala (p = 0.009), and overall NP (p = 0.014) as well as counts of NPs in all regions examined (p values ranging from 0.009 to 0.04). NP ratings in the hippocampus (p = 0.057) and the combined neocortical measure (p = 0.052) approached significance. In each analysis, the concomitant medication group had significantly fewer NPs (approximately 20%) than any of the other groups, which were relatively similar. No significant NFT differences were found. CONCLUSION: The results of this study suggest that the combination of insulin with other diabetes medication is associated with substantially lower neuritic plaque density consistent with the effects of both on the neurobiology of insulin.


Subject(s)
Brain/pathology , Diabetes Mellitus/drug therapy , Diabetes Mellitus/pathology , Hypoglycemic Agents/therapeutic use , Insulin/therapeutic use , Neurofibrillary Tangles/pathology , Plaque, Amyloid/pathology , Aged , Aged, 80 and over , Analysis of Variance , Brain/drug effects , Case-Control Studies , Drug Therapy, Combination , Female , Humans , Male , Neurofibrillary Tangles/drug effects , Plaque, Amyloid/drug effects , Postmortem Changes , Psychiatric Status Rating Scales , Severity of Illness Index
8.
Rev Sci Instrum ; 78(2): 023503, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17578109

ABSTRACT

To study electron cylotron resonance (ECR) breakdown and afterglow plasma in an experimental linear plasma system, a pulsed microwave source with rapid rise and fall of microwave power is desired. A pulsed microwave source with fast rise and fall capability for ECR breakdown experiments has been designed and tested for performance in the system. A tetrode, controlled by a modulator card, is used as a fast switch to initiate microwave power from a conventional magnetron operating at 2.45 GHz. The typical rise time of microwave power is approximately 3 micros and a fall time of approximately 10 micros. Using this scheme in a realistic pulsed microwave source at 800 W power, ECR breakdown of neutral gas is achieved and the plasma delay and fall time are observed from the plasma density measurements using a Langmuir probe. The design details of the fast rise pulsed microwave source are presented in this article with initial experimental results.

9.
Neurobiol Aging ; 28(1): 1-7, 2007 Jan.
Article in English | MEDLINE | ID: mdl-16343696

ABSTRACT

The degree to which neurofibrillary tangles (NFT), the hallmark lesions of Alzheimer disease (AD), contribute to the development of the cognitive symptoms of AD has been debated. NFTs are comprised of abnormally phosphorylated and conformationally altered tau proteins. Conformational changes in tau have been proposed to be among the earliest neurobiological changes in AD. This study examined whether conformational changes detected by antibodies MC1 and TG3 represent early abnormalities in the disease process by assessing their presence at different stages of dementia in multiple brain regions. Postmortem specimens from several neocortical regions were examined for conformational changes in tau by ELISA in subjects [n=81] who died at different stages of cognitive impairment. Concentrations of conformationally altered tau increased with increasing dementia severity and the levels of MC1 immunoreactivity increased in the frontal cortex of mildly demented subjects before the appearance of NFT bearing neurons, suggesting that conformational alterations in tau occur early in the course of AD and its cognitive symptoms and may precede histologically identified NFTs.


Subject(s)
Aging/metabolism , Aging/pathology , Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Brain Chemistry , Brain/pathology , tau Proteins/chemistry , Aged , Aged, 80 and over , Disease Progression , Female , Humans , In Vitro Techniques , Male , Middle Aged , tau Proteins/classification
10.
Neurology ; 66(9): 1399-404, 2006 May 09.
Article in English | MEDLINE | ID: mdl-16682673

ABSTRACT

OBJECTIVE: To examine the associations between postmortem Alzheimer disease (AD) neuropathology and autopsy-verified cardiovascular disease. METHODS: The authors examined 99 subjects (mean age at death = 87.6; SD = 8.7) from the Mount Sinai School of Medicine Department of Psychiatry Brain Bank who were devoid of cerebrovascular disease-associated lesions or of non-AD-related neuropathology. Density of neuritic plaques (NPs) and neurofibrillary tangles (NFTs) as well as coronary artery and aortic atherosclerosis, left ventricular wall thickness, and heart weight were measured. Partial correlations were used to assess the associations of the four cardiovascular variables with NPs and NFTs in the hippocampus, entorhinal cortex, and multiple regions of the cerebral cortex after controlling for age at death, sex, dementia severity, body mass index, and ApoE genotype. These analyses were also repeated separately for ApoE4 carriers and noncarriers. RESULTS: The extent of coronary artery disease and to a lesser extent atherosclerosis were significantly associated with the density of cardinal neuropathologic lesions of AD in this autopsy sample (significant correlations between 0.22 and 0.29). These associations were more pronounced for the ApoE4 allele carriers (n = 42; significant correlations between 0.34 and 0.47). CONCLUSIONS: The degree of coronary artery disease is independently associated with the cardinal neuropathological lesions of Alzheimer disease. These associations are primarily attributable to individuals with the ApoE4 allele.


Subject(s)
Alzheimer Disease/complications , Apolipoproteins E/genetics , Coronary Disease/complications , Aged, 80 and over , Alleles , Alzheimer Disease/genetics , Alzheimer Disease/pathology , Aortic Diseases/complications , Aortic Diseases/genetics , Apolipoprotein E4 , Atherosclerosis/complications , Atherosclerosis/genetics , Brain/pathology , Cardiomegaly/complications , Cardiomegaly/genetics , Cardiomegaly/pathology , Comorbidity , Coronary Disease/genetics , Female , Genetic Predisposition to Disease , Genotype , Heart Ventricles/pathology , Humans , Male , Neurofibrillary Tangles , Organ Size , Plaque, Amyloid , Severity of Illness Index
11.
Parkinsonism Relat Disord ; 9(4): 225-31, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12618058

ABSTRACT

A multigenerational family complex with an admixture of essential tremor (ET) and PD is presented. Medical information obtained either by historic documentation and/or examination was available for five generations and included 36 members. Of these, 11 family members had tremor of the limbs and/or head. In all these instances ET made its first appearance at an early age, usually prior to the second decade of life. In one case focal dystonia of the hand, a possible prelude to PD occurred, while in three brothers of the third generation, two of them identical twins, classical Parkinson's disease (PD) developed. They had ET develop at an early age, which persisted and in their 50s began showing evidence of PD. Two decades later the twin brothers succumbed to cancer of the colon and at autopsy typical findings of PD with cell loss in the substantia nigra and Lewy-body formation positive for alpha-synuclein by immunohistochemistry was found. Additionally, more than the usual number of senile plaques and neurofibrillatory tangles were present without clinical evidence of dementia or significant decline in cognitive function. This unusual set of clinical and pathological circumstances can hardly be attributed to chance occurrence and raise the question of a specific genetic mutation and/or clustering, which may link ET with PD.


Subject(s)
Essential Tremor/complications , Parkinson Disease/complications , Adult , Aged , Autopsy , Basal Ganglia/pathology , Brain/pathology , Essential Tremor/pathology , Family , Female , Humans , Hypertension/complications , Hypertension/physiopathology , Lewy Bodies/pathology , Male , Middle Aged , Neurofibrillary Tangles/pathology , Organ Size , Parkinson Disease/pathology , Pedigree , Plaque, Amyloid/pathology , Substantia Nigra/pathology
12.
J Environ Biol ; 24(3): 213-21, 2003 Jul.
Article in English | MEDLINE | ID: mdl-15259596

ABSTRACT

Mycotoxins are fungal secondary metabolites formed by consecutive series of enzyme-catalysed reactions from a few biochemically simple intermediates of primary metabolism. These mycotoxins can enter the human and animal food chain by direct or indirect contamination. Mycotoxins are equally harmful to animal and human beings. Realizing the importance of mycotoxins to the health of man and animals there have been concentrated efforts to develop highly sensitive analytical methods for detection and proper determination of mycotoxins in food, mixed feeds and feed ingredients, animal tissue, blood, urine and milk. Most of the mycotoxins are identified and most current research on it is concentrated on increasing sensitivity accuracy and reproducibility and above all to decrease the time of determination. A detailed review of mycotoxin and their detection is summarised in the paper.


Subject(s)
Food Contamination , Fungi/pathogenicity , Mycotoxins/toxicity , Animals , Epidemiologic Studies , Humans , Risk Assessment
13.
Arch Neurol ; 58(12): 2025-32, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11735776

ABSTRACT

CONTEXT: Accumulation of senile plaques containing amyloid beta (Abeta)-protein is a pathologic hallmark of Alzheimer disease. Amyloid beta-peptide is heterogeneous, with carboxyterminal variants ending at residues Val40 (Abetax-40), Ala42 (Abetax-42), or Thr43 (Abetax-43). The relative importance of each of these variants in dementia or cognitive decline remains unclear. OBJECTIVE: To study whether Abeta deposition correlates with dementia and occurs at the earliest signs of cognitive decline. DESIGN, SETTING, AND PATIENTS: Postmortem cross-sectional study comparing the deposition of Abeta variants in the prefrontal cortex of 79 nursing home residents having no, questionable, mild, moderate, or severe dementia. MAIN OUTCOME MEASURES: Levels of staining of Abeta-peptides ending at amino acid 40, 42, or 43 in the frontal cortex, as a function of Clinical Dementia Rating score. RESULTS: There were significant deposits of all 3 Abeta species that strongly correlated with cognitive decline. Furthermore, deposition of Abetax-42 and Abetax-43 occurred very early in the disease process before there could be a diagnosis of Alzheimer disease. Levels of deposited Abetax-43 appeared surprisingly high given the low amounts synthesized. CONCLUSIONS: These data indicate that Abetax-42 and Abetax-43 are important species associated with early disease progression and suggest that the physiochemical properties of the Abeta species may be a major determinant in amyloid deposition. The results support an important role for Abeta in mediating initial pathogenic events in Alzheimer disease dementia and reinforce that treatment strategies targeting the formation, accumulation, or cytotoxic effects of Abeta should be pursued.


Subject(s)
Amyloid beta-Peptides/genetics , Cognition Disorders/genetics , Plaque, Amyloid/genetics , Aged , Aged, 80 and over , Alzheimer Disease/genetics , Alzheimer Disease/pathology , Alzheimer Disease/psychology , Amyloid beta-Peptides/metabolism , Antibodies, Monoclonal , Cognition Disorders/pathology , Cognition Disorders/psychology , Cross-Sectional Studies , Disease Progression , Enzyme-Linked Immunosorbent Assay , Female , Humans , Immunoelectrophoresis , Immunohistochemistry , Male , Middle Aged , Plaque, Amyloid/pathology , Prefrontal Cortex/pathology , Psychiatric Status Rating Scales
14.
J Neurosurg ; 94(2 Suppl): 305-9, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11302637

ABSTRACT

This case of a 68-year-old woman with a low-thoracic intramedullary neurenteric cyst is notable for clinical presentation, cyst location, intraoperative findings, and imaging characteristics. The patient's postoperative course was complicated by neurological deterioration and a neuropathic pain syndrome. Potential causes of these complications are discussed, as are possible ways to reduce the risk of their occurrence.


Subject(s)
Medulla Oblongata , Neural Tube Defects/diagnosis , Neural Tube Defects/surgery , Neurosurgical Procedures , Spinal Cord Diseases/diagnosis , Spinal Cord Diseases/surgery , Aged , Female , Humans , Magnetic Resonance Imaging , Nervous System Diseases/etiology , Neural Tube Defects/pathology , Pain, Postoperative/physiopathology , Postoperative Complications , Spinal Cord Diseases/pathology , Thoracic Vertebrae
15.
J Perinatol ; 21(1): 21-6, 2001.
Article in English | MEDLINE | ID: mdl-11268863

ABSTRACT

OBJECTIVE: Numerous risk factors for development of retinopathy of prematurity (ROP) in very low birth weight infants have been identified in the literature. However, the role of anemia in the development of ROP has not been adequately addressed. STUDY DESIGN: We retrospectively examined the medical records of all infants weighing < or = 800 g who were admitted to a university hospital between July 1, 1992 and December 30, 1997. Highest and lowest hemoglobin and hematocrit values and the number of blood transfusions were recorded at each week of life during hospitalization. Gestational age at birth, birth weight, race, sex, oxygen status, history of bronchopulmonary dysplasia, length of hospital stay, and sepsis were also identified as potential risk factors. Data were analyzed using logistic regression to adjust for these confounding variables. RESULTS: Infants were grouped according to ROP status in the following manner: stage 0 to 1 ROP, stage 2 ROP, and stage 3 to threshold ROP. Sex, gestational age at birth, bronchopulmonary dysplasia, ventilator days, length of hospital stay, and number of blood transfusions were significantly associated with severity of ROP by univariate analysis. Using a logistic regression model, only gestational age (p = 0.007) and number of blood transfusions (p = 0.04) remained statistically significant. CONCLUSIONS: Anemia did not affect severity of ROP as an independent risk factor. However, the number of blood transfusions did affect the highest stage of ROP in this group of premature infants. Infants who remained severely anemic (Hgb < or = 8 g/dl or Hct < or = 25%) for longer periods of time developed milder ROP than less anemic infants.


Subject(s)
Anemia/epidemiology , Infant, Very Low Birth Weight , Retinopathy of Prematurity/epidemiology , Blood Transfusion , Female , Humans , Infant, Newborn , Logistic Models , Male , Retrospective Studies , Risk Factors
16.
Arch Neurol ; 58(3): 487-92, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11255454

ABSTRACT

BACKGROUND: Prior studies have shown that cyclooxygenase 2 (COX-2), an enzyme involved in inflammatory mechanisms and neuronal activities, is up-regulated in the brain with Alzheimer disease (AD) and may represent a therapeutic target for anti-inflammatory treatments. OBJECTIVE: To explore COX-2 expression in the brain as a function of clinical progression of early AD. DESIGN AND MAIN OUTCOME MEASURES: Using semiquantitative immunocytochemistry, we analyzed COX-2 protein content in the hippocampal formation in 54 postmortem brain specimens from patients with normal or impaired cognitive status. SETTING AND PATIENTS: Postmortem study of nursing home residents. RESULTS: The immunointensity of COX-2 signal in the CA3 and CA2 but not CA1 subdivisions of the pyramidal layers of the hippocampal formation of the AD brain increased as the disease progressed from questionable to mild clinical dementia as assessed by Clinical Dementia Rating. COX-2 signal was increased in all 3 regions examined among cases characterized by severe dementia. CONCLUSION: Neuronal COX-2 content in subsets of hippocampal pyramidal neurons may be an indicator of progression of dementia in early AD.


Subject(s)
Alzheimer Disease/metabolism , Alzheimer Disease/pathology , Hippocampus/enzymology , Hippocampus/pathology , Isoenzymes/biosynthesis , Prostaglandin-Endoperoxide Synthases/biosynthesis , Aged , Aged, 80 and over , Cyclooxygenase 2 , Disease Progression , Female , Humans , Immunohistochemistry , Isoenzymes/analysis , Male , Membrane Proteins , Prostaglandin-Endoperoxide Synthases/analysis
17.
Pediatrics ; 107(3): 549-52, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11230598

ABSTRACT

OBJECTIVE: To characterize the international experience concerning neonates with trisomy 21 (T21) managed with extracorporeal membrane oxygenation (ECMO), and to compare and contrast this group of patients to the neonatal ECMO population as a whole. METHODS: Data from the Extracorporeal Life Support Organization for newborn infants placed on ECMO between January 1984 and June 1999 were analyzed. Infants with T21 were compared with the group of infants without T21. RESULTS: Fifteen thousand nine hundred forty-six infants, including 91 (n = 91) with the diagnosis of T21, were placed on ECMO for neonatal respiratory failure during the 14.5-year period. T21 infants were overrepresented in the ECMO population by several-fold when compared with the incidence of T21 in the general population. Eighty-seven of the 91 T21 infants were placed on ECMO after 1989. The distribution of primary diagnoses leading to ECMO differed between the groups (T21 vs non-T21): primary persistent pulmonary hypertension, 47.3% versus 13%; meconium aspiration syndrome, 23.1% versus 32.9%; sepsis, 7.7% versus 13.2%; congenital diaphragmatic hernia, 7.7% versus 19.9%; and respiratory distress syndrome, 3.3% versus 7.9%. Although survival to discontinuation of ECMO was similar in the 2 groups, likelihood of survival to discharge was decreased for T21 infants (65.9% vs 75.6%) because of increased post-ECMO mortality. CONCLUSIONS: Extracorporeal Life Support Organization registry data suggests that T21 infants are at a significantly higher risk of being placed on ECMO for neonatal respiratory failure than the general population, perhaps as a result of delayed extrauterine pulmonary vascular adaptation, as manifested in the high rate of primary persistent pulmonary hypertension as the primary diagnosis. There may have been a shift in attitude regarding the use of ECMO in the T21 patient after 1989. Although most T21 patients placed on ECMO will survive, the prognosis is more guarded in this population when compared with all infants so managed. The long-term neurodevelopmental outcome of this group of T21 ECMO survivors is currently unknown.


Subject(s)
Down Syndrome , Extracorporeal Membrane Oxygenation , Intensive Care, Neonatal/trends , Respiratory Distress Syndrome, Newborn/therapy , Down Syndrome/complications , Extracorporeal Membrane Oxygenation/statistics & numerical data , Humans , Infant, Newborn , Persistent Fetal Circulation Syndrome/complications , Prognosis , Respiratory Distress Syndrome, Newborn/complications
18.
Neurosci Lett ; 298(3): 191-4, 2001 Feb 09.
Article in English | MEDLINE | ID: mdl-11165439

ABSTRACT

Using a cDNA microarray representing 6794 distinct human genes, we identified candidate genes whose expression is altered in cerebral cortex of cases of early Alzheimer's disease (AD); among these was the synaptic vesicle protein synapsin II, which plays an important role in neurotransmitter release. While other candidate genes are presently under investigation in our lab, in this study we discuss the regulation of synapsin gene expression during the transition from normal cognitive function to early AD. We found a selective decrease in the expression of the synapsin splice variants I-III of the a-type isoform in the entorhinal (EC, BM36) but not visual cortex (VC, BM17) of cases characterized by the earliest clinically detectable stage of AD. In contrast, we found no changes in synapsin splice variant II of the b-type isoform. Alteration of synapsin expression at the earliest clinical stage of AD may suggest novel strategies for improved treatment.


Subject(s)
Alzheimer Disease/physiopathology , Brain Chemistry/genetics , Oligonucleotide Array Sequence Analysis , Synapsins/genetics , Aged , Aged, 80 and over , Alternative Splicing , Alzheimer Disease/epidemiology , Alzheimer Disease/genetics , Entorhinal Cortex/physiopathology , Female , Gene Expression , Humans , Isomerism , Male , Risk Factors , Synapsins/chemistry , Visual Cortex/physiopathology
20.
Arch Neurol ; 57(8): 1145-50, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10927794

ABSTRACT

CONTEXT: Lewy bodies (LBs) are intraneuronal inclusions in the brain that have been increasingly recognized as neuropathological lesions with relevance not only to Parkinson disease but also to Alzheimer disease. However, the degree to which the density of LBs in the brain contributes to the severity of dementia has not been clear. OBJECTIVE: To determine the degree to which LB "burden" contributes to dementia. DESIGN: Brain specimens were examined from 273 consecutive autopsies of elderly subjects residing in a nursing home. The numbers and densities of LBs were determined in multiple brain regions, and their correlation with a measure of cognition and functional status (Clinical Dementia Rating) during the 6 months preceding death was determined. SETTING AND PATIENTS: Postmortem study of nursing home residents. RESULTS: The severity of dementia correlated significantly and positively with the density of LBs. These correlations were independent of other neuropathological disorders commonly associated with dementia, including Alzheimer disease. The density of LBs correlated significantly with dementia severity whether or not the diagnostic criteria for Alzheimer disease were met and after the contribution of classical Alzheimer disease lesions, neuritic plaques, and neurofibrillary tangles had been accounted for by partial correlation analysis. CONCLUSION: Lewy body inclusions appear to contribute significantly to cognitive deficits in the elderly in a manner that is independent of other neuropathological disorders. Arch Neurol. 2000;57:1145-1150


Subject(s)
Alzheimer Disease/pathology , Brain/pathology , Lewy Bodies/pathology , Lewy Body Disease/pathology , Aged , Aged, 80 and over , Cognition , Cohort Studies , Female , Humans , Male , Mental Status Schedule , Middle Aged , Neuropsychological Tests , Retrospective Studies , Severity of Illness Index
SELECTION OF CITATIONS
SEARCH DETAIL
...